Fibrinogen is an antioxidant that protects β-lipoproteins at physiological concentrations in a cell free system

Atherosclerosis

Volumn 158, Issue 2, 2001, Pages 455-463

  Kaplan, Irina V ^a   Attaelmannan, Mohammed ^a   Levinson, Stanley S ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Tel: +1 502 8953401 ^*  (United States)

Author keywords

Antioxidants; Arteriosclerosis; Coronary artery disease; Fibrinogen

Indexed keywords

ALBUMIN; ALKADIENE; ALPHA TOCOPHEROL; APOLIPOPROTEIN; ASCORBIC ACID; COPPER; FIBRINOGEN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MELATONIN; PEROXIDE; PROTEIN; TROLOX C;

ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CELL FREE SYSTEM; CHELATION; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN TISSUE; LIPOPROTEIN METABOLISM; METABOLIC INHIBITION; OXIDATION; PHYSICAL CHEMISTRY; PHYSIOLOGY; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION;

ANTIOXIDANTS; ASCORBIC ACID; CHROMATOGRAPHY, AFFINITY; COPPER; ELECTROPHORESIS, AGAR GEL; FIBRINOGEN; HUMANS; HYDROGEN PEROXIDE; LIPOPROTEINS, LDL; MELATONIN; OXIDATION-REDUCTION; SERUM ALBUMIN; VITAMIN E;

EID: 0034813754     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00452-X     Document Type: Article

References (46)

1. Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity
2. Role of oxidized low density lipoprotein in atherosclerosis
3. Antioxidant defences and lipid peroxidation in human blood plasma
4. Albumin - An important extracellular antioxidant?
5. Oxidative processes and antioxidant defence mechanisms in the aging brain
6. Fibrinogen viscosity and white blood cell count are major risk factors for ischemic heart disease
7. Fibrinogen and risk of cardiovascular disease
8. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men
9. A prospective study of fibrinogen and risk of myocardial infarction in the physicians' health study
10. Plasma fibrinogen - An independent cardiovascular risk factor
11. Hemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris
12. Prognostic influences of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
13. Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassay
14. The antioxidative action of fibrinogen and the implications of the effect on platelet aggregation
15. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation
16. Simpler technique for measuring oxidative susceptibility by heparin affinity column isolation of lipoproteins
17. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease
18. Vitamins and especially flavonoids in common beverages are powerful in vitro antioxidants which enrich lower density lipoproteins and increase their oxidative resistance after ex vivo spiking in human plasma
19. Characterization and metabolic fate of two very low-density lipoprotein subfractions separated by heparin-sepharose chromatography
20. Continuous monitoring of in vitro oxidation of human low density lipoprotein
21. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein
22. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
23. Immunofixation electrophoretic techniques applied to identification of proteins in serum and cerebrospinal fluid
24. Relationship between bilirubin, apolipoprotein B and risk of coronary artery disease
25. Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations
26. Melatonin and radioprotection from genetic damage: In vivo/in vitro studies with human volunteers
27. The role of metabolism in the antioxidant function of vitamin E
28. The chemistry and antioxidant properties of tocopherols and tocotrienols
29. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
30. Paradoxical actions of antioxidants in the oxidation of low density lipoproteins by peroxidases
31. Catalytic metals, ascorbate and free radicals: Combinations to avoid
32. Functional consequences of tryptophan modification in human fibrinogen
33. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: A clinical biochemistry perspective
34. On the antioxidant activity of melatonin
35. Fibrinogen structure and physiology
36. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats
37. The effect of fibrinopeptides A and B on experimental allergenic encephalomyelitis
38. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats
39. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis
40. Fibrinogen association with monocytes: Evidence for constitutive expression of fibrinogen receptors and for involvement of MAC-1 (CD18, CR3) in the binding
41. Low-affinity interaction of fibrinogen carboxy-gamma terminus with human monocytes induce an oxidative burst and modulates effector function
42. Mechanisms of disease: Antioxidants
43. Atorvastatin; an effective lipid-modifying agent in familiar hypercholesterolemia
44. Pravastatin therapy in hyperlipidemia: Effects on thrombus formation and the systemic hemostatic profile
45. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia